BioSistemika

BioSistemika

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $700K

Overview

BioSistemika is a private, revenue-generating services and software company based in Ljubljana, Slovenia, focusing on the digital health and AI/machine learning sectors. Its core business involves building custom, compliant laboratory software (e.g., for LIMS, ELN) and providing digital transformation services for instrument manufacturers, labs, and software providers. The company differentiates itself through deep domain expertise combining scientists and engineers and is exploring a novel, patented DNA data storage technology through an internal project called DATANA.

Digital HealthAI / Machine Learning

Technology Platform

Service platform for developing custom, regulatory-compliant laboratory informatics software (LIMS, ELN, analytical software) and a patented DNA data storage technology (DATANA).

Funding History

2
Total raised:$700K
Grant$200K
Seed$500K

Opportunities

The growing demand for laboratory digitalization and regulatory-compliant software in pharma, biotech, and IVD sectors presents a substantial services opportunity.
The internal DATANA DNA data storage project offers a long-term, high-potential opportunity in the emerging field of sustainable, high-density archival data storage.

Risk Factors

Revenue is dependent on project-based services, making it susceptible to economic cycles and client spending cuts.
The core business faces significant regulatory execution risk, and the speculative DATANA R&D project requires sustained investment with an uncertain commercial timeline and outcome.

Competitive Landscape

BioSistemika competes in a fragmented market with large laboratory informatics vendors (e.g., Thermo Fisher, LabVantage), specialized software developers, and digital transformation consultancies. Its differentiation lies in its deep integration of life science domain expertise with software engineering and a strong focus on regulatory compliance for medical devices.